BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,385.00
+10.00 (0.23%)
Last updated: Jun 24, 2026, 2:15 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 442.71 billion as of June 24, 2026. Its market cap has decreased by -12.30% in one year.
Market Cap
442.71B
Enterprise Value
82.70B
Revenue
122.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,385.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 442.71B, a decrease of -59.20%. That is a compound annual growth rate of -22.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 442.71B | -20.15% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 3.05T |
| SD Biosensor | 811.36B |
| T&L Co., Ltd. | 440.94B |
| Value Added Technology | 278.07B |
| Vieworks | 213.26B |
| Shinhung | 128.26B |
| Dongbang Medical | 117.65B |
| EOFLOW | 51.11B |